Global Boronate Affinity Tests Market-Industry Analysis, Growth, Trends and Forecast- 2019-2027

The global Boronate affinity Tests market is expected to witness CAGR of 5% in forecast period to reach xxx MN by 2027 from xxx MN in 2019. Boronate affinity Tests are widely used to measure the total glycated haemoglobin, consisting of HbA1c and other Hb variants regardless of the charge. It is a chromatographic technique for the quantitation of glycosylated haemoglobin using a boronic acid affinity support. The glycosylated haemoglobin gets bound to the immobilized boronic acid, which helps them to separate from non-glycosylated haemoglobin. It measures the total glycosylated haemoglobin (GHb), including HBA1c and Hb glycated at other sites. This test is conducted on people with Type 1 and Type 2 diabetes.

Global Boronate Affinity Tests Market Dynamics

Increasing number of diabetic’s patients in China, India, Brazil, and South Africa is expected to drive the market for The Boronate affinity tests in forecast period. As on 2020, number of diabetics’ patients in China, India, Brazil and South Africa was xx MN, xx MN, xx MN and XX MN respectively and total number of diabetics patients in these four countries is expected to be XXX MN by 2027. The increasing diabetic population in these focused countries are expected to drive the market for Boronate affinity-based HBA1c laboratory tests. Country wise analysis of increment in the patients and the current tests in the industry are analysed with the share of Boronate affinity-based HBA1c. According to CDC, around 34.2 million people were suffering from diabetes in 2019, while 88 million US adults were prediabetic. Routine tests for corporate employees by the company and government wellness programs have increased the market for Boronate affinity testing. The migration of R&D facilities from western countries to the developing nations in APAC due to low labour costs is expected to increase demand for Boronate affinity chromatography products and similar other laboratory equipment in the forecast period. The rapidly increasing chemical industry and investments from private investors is also having a positive impact on the market.

Global Boronate Affinity Tests Market Segmentation

The market is segmented as: By technology, by indication, by region

Global Boronate Affinity Tests market, by technology

• Boronate Affinity Chromatography • Boronate Affinity high-performance liquid chromatography • Ion-exchange HPLC Global Boronate Affinity Tests Market To know about the Research Methodology :- Request Free Sample Report

Technology Segment Analysis

The ion-exchange high performance liquid chromatography (HPLC) segment accounted for the largest share of the global Boronate Affinity Tests market in 2019.This segment is expected to expand at a significant CAGR during the forecast period. High Performance Liquid Chromatography increases ionic strength of buffer, identifies variants, and consumes less time. Hence, the segment is likely to dominate the market during the forecast period.

Scope of the Global Boronate Affinity Tests Market: Inquire before buying

Global Boronate Affinity Tests Market, by Indication

• Type 1 diabetes • Type 2 diabetes

Global Boronate Affinity Tests Market, by Region

Global Boronate Affinity Tests Market1 North America to dominate the Global Boronate Affinity Tests Market North America is expected to lead the market in the forecast period. The advancements in accurate diagnostic tests and adoption of advanced techniques has lead the country to top in the Boronate affinity tests market. Increase in diabetic population, Increase in awareness about this test and rise in physician prescriptions for this test are expected to elevate the market in this region. Laboratory equipment manufacturers of this test are entering into partnership with laboratories, thereby driving the market. Increase in funding by the government authorities, favourable reimbursement policies and an increase in diabetic and geriatric population is leading to a rise in number of laboratories for Boronate affinity tests. The objective of the report is to present a comprehensive analysis of the Global Boronate Affinity Tests Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers, and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analysed, which will give a clear futuristic view of the industry to the decision-makers. The report also helps in understanding Global Boronate Affinity Tests Market dynamics, structure by analyzing the market segments and project the Global Boronate Affinity Tests size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Boronate Affinity Tests Market make the report investor’s guide.

Leading players operating the Global Boronate Affinity Tests Market

• Abbott Laboratories • A. Menarini Diagnostics s.r.l • GREENCORSS MEDIS Corp • Alere Inc. • Trinity Biotech • HUMAN DIgnostics • HemoCue • ARKRAY, Inc. • Beckman Coulter, Inc • Bio-Rad Laboratories, Inc. • Diazyme Laboratories, Inc. • EKF Diagnostics Holdings plc • OSANG Healthcare Co. Ltd • PTS Diagnostics • Roche Diagnostics • Siemens Healthineers • Tosoh Bioscience, Inc. • Trinity Biotech plc
Global Boronate Affinity Tests Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Boronate Affinity Tests Market Size, by Market Value (US$ Mn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Global Boronate Affinity Tests Market Analysis and Forecast 6.1. Boronate Affinity Tests Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Boronate Affinity Tests Market Analysis and Forecast, By Indication 7.1. Introduction and Definition 7.2. Key Findings 7.3. Boronate Affinity Tests Market Value Share Analysis, By Indication 7.4. Boronate Affinity Tests Market Size (US$ Mn) Forecast, By Indication 7.5. Boronate Affinity Tests Market Analysis, By Indication 7.6. Boronate Affinity Tests Market Attractiveness Analysis, By Indication 8. Global Boronate Affinity Tests Market Analysis and Forecast, By Technology 8.1. Introduction and Definition 8.2. Key Findings 8.3. Boronate Affinity Tests Market Value Share Analysis, By Technology 8.4. Boronate Affinity Tests Market Size (US$ Mn) Forecast, By Technology 8.5. Boronate Affinity Tests Market Analysis, By Technology 8.6. Boronate Affinity Tests Market Attractiveness Analysis, By Technology 9. Global Boronate Affinity Tests Market Analysis, by Region 9.1. Boronate Affinity Tests Market Value Share Analysis, by Region 9.2. Boronate Affinity Tests Market Size (US$ Mn) Forecast, by Region 9.3. Boronate Affinity Tests Market Attractiveness Analysis, by Region 10. North America Boronate Affinity Tests Market Analysis 10.1. Key Findings 10.2. North America Boronate Affinity Tests Market Overview 10.3. North America Boronate Affinity Tests Market Value Share Analysis, By Indication 10.4. North America Boronate Affinity Tests Market Forecast, By Indication 10.4.1. Type 1 diabetes 10.4.2. Type 2 diabetes 10.5. North America Boronate Affinity Tests Market Value Share Analysis, By Technology 10.6. North America Boronate Affinity Tests Market Forecast, By Technology 10.6.1. Boronate Affinity Chromatography 10.6.2. Boronate Affinity high-performance liquid chromatography 10.6.3. Ion-exchange HPLC 10.7. North America Boronate Affinity Tests Market Value Share Analysis, by Country 10.8. North America Boronate Affinity Tests Market Forecast, by Country 10.8.1. U.S. 10.8.2. Canada 10.8.3. Mexico 10.9. North America Boronate Affinity Tests Market Analysis, by Country 10.10. U.S. Boronate Affinity Tests Market Forecast, By Indication 10.10.1. Type 1 diabetes 10.10.2. Type 2 diabetes 10.11. U.S. Boronate Affinity Tests Market Forecast, By Technology 10.11.1. Boronate Affinity Chromatography 10.11.2. Boronate Affinity high-performance liquid chromatography 10.11.3. Ion-exchange HPLC 10.12. Canada Boronate Affinity Tests Market Forecast, By Indication 10.12.1. Type 1 diabetes 10.12.2. Type 2 diabetes 10.13. Canada Boronate Affinity Tests Market Forecast, By Technology 10.13.1. Boronate Affinity Chromatography 10.13.2. Boronate Affinity high-performance liquid chromatography 10.13.3. Ion-exchange HPLC 10.14. Mexico Boronate Affinity Tests Market Forecast, By Indication 10.14.1. Type 1 diabetes 10.14.2. Type 2 diabetes 10.15. Mexico Boronate Affinity Tests Market Forecast, By Technology 10.15.1. Boronate Affinity Chromatography 10.15.2. Boronate Affinity high-performance liquid chromatography 10.15.3. Ion-exchange HPLC 10.16. North America Boronate Affinity Tests Market Attractiveness Analysis 10.16.1. By Indication 10.16.2. By Technology 10.17. PEST Analysis 10.18. Key Trends 10.19. Key Developments 11. Europe Boronate Affinity Tests Market Value Share Analysis, By Indication 11.1. Europe Boronate Affinity Tests Market Forecast, By Indication 11.1.1. Type 1 diabetes 11.1.2. Type 2 diabetes 11.2. Europe Boronate Affinity Tests Market Forecast, By Technology 11.2.1. Boronate Affinity Chromatography 11.2.2. Boronate Affinity high-performance liquid chromatography 11.2.3. Ion-exchange HPLC 11.3. Europe Boronate Affinity Tests Market Value Share Analysis, by Country 11.4. Europe Boronate Affinity Tests Market Forecast, by Country 11.4.1. Germany 11.4.2. U.K. 11.4.3. France 11.4.4. Italy 11.4.5. Spain 11.4.6. Sweden 11.4.7. CIS countries 11.4.8. Rest of Europe 11.5. Germany Boronate Affinity Tests Market Forecast, By Indication 11.5.1. Type 1 diabetes 11.5.2. Type 2 diabetes 11.6. Germany Boronate Affinity Tests Market Forecast, By Technology 11.6.1. Boronate Affinity Chromatography 11.6.2. Boronate Affinity high-performance liquid chromatography 11.6.3. Ion-exchange HPLC 11.7. U.K. Boronate Affinity Tests Market Forecast, By Indication 11.7.1. Type 1 diabetes 11.7.2. Type 2 diabetes 11.8. U.K. Boronate Affinity Tests Market Forecast, By Technology 11.8.1. Boronate Affinity Chromatography 11.8.2. Boronate Affinity high-performance liquid chromatography 11.8.3. Ion-exchange HPLC 12. France Boronate Affinity Tests Market Forecast, By Indication 12.1.1. Type 1 diabetes 12.1.2. Type 2 diabetes 12.2. France Boronate Affinity Tests Market Forecast, By Technology 12.2.1. Boronate Affinity Chromatography 12.2.2. Boronate Affinity high-performance liquid chromatography 12.2.3. Ion-exchange HPLC 12.3. Italy Boronate Affinity Tests Market Forecast, By Indication 12.3.1. Type 1 diabetes 12.3.2. Type 2 diabetes 12.4. Italy Boronate Affinity Tests Market Forecast, By Technology 12.4.1. Boronate Affinity Chromatography 12.4.2. Boronate Affinity high-performance liquid chromatography 12.4.3. Ion-exchange HPLC 12.5. Spain Boronate Affinity Tests Market Forecast, By Indication 12.5.1. Type 1 diabetes 12.5.2. Type 2 diabetes 12.6. Spain Boronate Affinity Tests Market Forecast, By Technology 12.6.1. Boronate Affinity Chromatography 12.6.2. Boronate Affinity high-performance liquid chromatography 12.6.3. Ion-exchange HPLC 12.7. Sweden Boronate Affinity Tests Market Forecast, By Indication 12.7.1. Type 1 diabetes 12.7.2. Type 2 diabetes 12.8. Sweden Boronate Affinity Tests Market Forecast, By Technology 12.8.1. Boronate Affinity Chromatography 12.8.2. Boronate Affinity high-performance liquid chromatography 12.8.3. Ion-exchange HPLC 12.9. CIS countries Boronate Affinity Tests Market Forecast, By Indication 12.9.1. Type 1 diabetes 12.9.2. Type 2 diabetes 12.10. CIS countries Boronate Affinity Tests Market Forecast, By Technology 12.10.1. Boronate Affinity Chromatography 12.10.2. Boronate Affinity high-performance liquid chromatography 12.10.3. Ion-exchange HPLC 12.11. Rest of Europe Boronate Affinity Tests Market Forecast, By Indication 12.11.1. Type 1 diabetes 12.11.2. Type 2 diabetes 12.12. Rest of Europe Boronate Affinity Tests Market Forecast, By Technology 12.12.1. Boronate Affinity Chromatography 12.12.2. Boronate Affinity high-performance liquid chromatography 12.12.3. Ion-exchange HPLC 12.13. Europe Boronate Affinity Tests Market Attractiveness Analysis 12.13.1. By Technology 12.13.2. By Indication 12.14. PEST Analysis 12.15. Key Trends 12.16. Key Developments 13. Asia Pacific Boronate Affinity Tests Market Analysis 13.1. Key Findings 13.2. Asia Pacific Boronate Affinity Tests Market Overview 13.3. Asia Pacific Boronate Affinity Tests Market Value Share Analysis, By Indication 13.4. Asia Pacific Boronate Affinity Tests Market Forecast, By Indication 13.4.1. Type 1 diabetes 13.4.2. Type 2 diabetes 13.5. Asia Pacific Boronate Affinity Tests Market Value Share Analysis, By Indication 13.6. Asia Pacific Boronate Affinity Tests Market Forecast, By Technology 13.6.1. Boronate Affinity Chromatography 13.6.2. Boronate Affinity high-performance liquid chromatography 13.6.3. Ion-exchange HPLC 13.7. Asia Pacific Boronate Affinity Tests Market Value Share Analysis, by Country 13.8. Asia Pacific Boronate Affinity Tests Market Forecast, by Country 13.8.1. China 13.8.2. India 13.8.3. Japan 13.8.4. South Korea 13.8.5. Australia 13.8.6. ASEAN 13.8.7. Rest of Asia Pacific 13.9. Asia Pacific Boronate Affinity Tests Market Analysis, by Country 13.10. China Boronate Affinity Tests Market Forecast, By Indication 13.10.1. Type 1 diabetes 13.10.2. Type 2 diabetes 13.11. China Boronate Affinity Tests Market Forecast, By Technology 13.11.1. Boronate Affinity Chromatography 13.11.2. Boronate Affinity high-performance liquid chromatography 13.11.3. Ion-exchange HPLC 13.12. India Boronate Affinity Tests Market Forecast, By Indication 13.12.1. Type 1 diabetes 13.12.2. Type 2 diabetes 13.13. India Boronate Affinity Tests Market Forecast, By Technology 13.13.1. Boronate Affinity Chromatography 13.13.2. Boronate Affinity high-performance liquid chromatography 13.13.3. Ion-exchange HPLC 13.14. Japan Boronate Affinity Tests Market Forecast, By Indication 13.14.1. Type 1 diabetes 13.14.2. Type 2 diabetes 13.15. Japan Boronate Affinity Tests Market Forecast, By Technology 13.15.1. Boronate Affinity Chromatography 13.15.2. Boronate Affinity high-performance liquid chromatography 13.15.3. Ion-exchange HPLC 13.16. South Korea Boronate Affinity Tests Market Forecast, By Indication 13.16.1. Type 1 diabetes 13.16.2. Type 2 diabetes 13.17. South Korea Boronate Affinity Tests Market Forecast, By Technology 13.17.1. Boronate Affinity Chromatography 13.17.2. Boronate Affinity high-performance liquid chromatography 13.17.3. Ion-exchange HPLC 13.18. Australia Boronate Affinity Tests Market Forecast, By Indication 13.18.1. Type 1 diabetes 13.18.2. Type 2 diabetes 13.19. Australia Boronate Affinity Tests Market Forecast, By Technology 13.19.1. Boronate Affinity Chromatography 13.19.2. Boronate Affinity high-performance liquid chromatography 13.19.3. Ion-exchange HPLC 13.20. ASEAN Boronate Affinity Tests Market Forecast, By Indication 13.20.1. Type 1 diabetes 13.20.2. Type 2 diabetes 13.21. ASEAN Boronate Affinity Tests Market Forecast, By Technology 13.21.1. Boronate Affinity Chromatography 13.21.2. Boronate Affinity high-performance liquid chromatography 13.21.3. Ion-exchange HPLC 13.22. Rest of Asia Pacific Boronate Affinity Tests Market Forecast, By Indication 13.22.1. Type 1 diabetes 13.22.2. Type 2 diabetes 13.23. Rest of Asia Pacific Boronate Affinity Tests Market Forecast, By Technology 13.23.1. Boronate Affinity Chromatography 13.23.2. Boronate Affinity high-performance liquid chromatography 13.23.3. Ion-exchange HPLC 13.24. Asia Pacific Boronate Affinity Tests Market Attractiveness Analysis 13.24.1. By Indication 13.24.2. By Technology 13.25. PEST Analysis 13.26. Key Trends 13.27. Key Developments 14. Middle East & Africa Boronate Affinity Tests Market Analysis 14.1. Key Findings 14.2. Middle East & Africa Boronate Affinity Tests Market Overview 14.3. Middle East & Africa Boronate Affinity Tests Market Value Share Analysis, By Indication 14.4. Middle East & Africa Boronate Affinity Tests Market Forecast, By Indication 14.4.1. Type 1 diabetes 14.4.2. Type 2 diabetes 14.5. Middle East & Africa Boronate Affinity Tests Market Forecast, By Technology 14.5.1. Boronate Affinity Chromatography 14.5.2. Boronate Affinity high-performance liquid chromatography 14.5.3. Ion-exchange HPLC 14.6. Middle East & Africa Boronate Affinity Tests Market Value Share Analysis, by Country 14.7. Middle East & Africa Boronate Affinity Tests Market Forecast, by Country 14.7.1. GCC Countries 14.7.2. South Africa 14.7.3. Nigeria 14.7.4. Egypt 14.7.5. Rest of Middle East & Africa 14.8. Middle East & Africa Boronate Affinity Tests Market Analysis, by Country 14.9. GCC Countries Boronate Affinity Tests Market Forecast, By Indication 14.9.1. Type 1 diabetes 14.9.2. Type 2 diabetes 14.10. GCC Countries Boronate Affinity Tests Market Forecast, By Technology 14.10.1. Boronate Affinity Chromatography 14.10.2. Boronate Affinity high-performance liquid chromatography 14.10.3. Ion-exchange HPLC 14.11. South Africa Boronate Affinity Tests Market Forecast, By Indication 14.11.1. Type 1 diabetes 14.11.2. Type 2 diabetes 14.12. South Africa Boronate Affinity Tests Market Forecast, By Technology 14.12.1. Boronate Affinity Chromatography 14.12.2. Boronate Affinity high-performance liquid chromatography 14.12.3. Ion-exchange HPLC 14.13. Nigeria Boronate Affinity Tests Market Forecast, By Indication 14.13.1. Type 1 diabetes 14.13.2. Type 2 diabetes 14.14. Nigeria Boronate Affinity Tests Market Forecast, By Technology 14.14.1. Boronate Affinity Chromatography 14.14.2. Boronate Affinity high-performance liquid chromatography 14.14.3. Ion-exchange HPLC 14.15. Egypt Boronate Affinity Tests Market Forecast, By Indication 14.15.1. Type 1 diabetes 14.15.2. Type 2 diabetes 14.16. Egypt Boronate Affinity Tests Market Forecast, By Technology 14.16.1. Boronate Affinity Chromatography 14.16.2. Boronate Affinity high-performance liquid chromatography 14.16.3. Ion-exchange HPLC 14.17. Rest of Middle East & Africa Boronate Affinity Tests Market Forecast, By Indication 14.17.1. Type 1 diabetes 14.17.2. Type 2 diabetes 14.18. Rest of Middle East & Africa Boronate Affinity Tests Market Forecast, By Technology 14.18.1. Boronate Affinity Chromatography 14.18.2. Boronate Affinity high-performance liquid chromatography 14.18.3. Ion-exchange HPLC 14.19. Middle East & Africa Boronate Affinity Tests Market Attractiveness Analysis 14.19.1. By Indication 14.19.2. By Technology 14.20. PEST Analysis 14.21. Key Trends 14.22. Key Developments 15. South America Boronate Affinity Tests Market Analysis 15.1. Key Findings 15.2. South America Boronate Affinity Tests Market Overview 15.3. South America Boronate Affinity Tests Market Value Share Analysis, By Indication 15.4. South America Boronate Affinity Tests Market Forecast, By Indication 15.4.1. Type 1 diabetes 15.4.2. Type 2 diabetes 15.5. South America Boronate Affinity Tests Market Forecast, By Technology 15.5.1. Boronate Affinity Chromatography 15.5.2. Boronate Affinity high-performance liquid chromatography 15.5.3. Ion-exchange HPLC 15.6. South America Boronate Affinity Tests Market Value Share Analysis, by Country 15.7. South America Boronate Affinity Tests Market Forecast, by Country 15.7.1. Brazil 15.7.2. Colombia 15.7.3. Argentina 15.7.4. Rest of South America 15.8. South America Boronate Affinity Tests Market Analysis, by Country 15.9. Brazil Boronate Affinity Tests Market Forecast, By Indication 15.9.1. Type 1 diabetes 15.9.2. Type 2 diabetes 15.10. Brazil Boronate Affinity Tests Market Forecast, By Technology 15.10.1. Boronate Affinity Chromatography 15.10.2. Boronate Affinity high-performance liquid chromatography 15.10.3. Ion-exchange HPLC 15.11. Colombia Boronate Affinity Tests Market Forecast, By Indication 15.11.1. Type 1 diabetes 15.11.2. Type 2 diabetes 15.12. Colombia Boronate Affinity Tests Market Forecast, By Technology 15.12.1. Boronate Affinity Chromatography 15.12.2. Boronate Affinity high-performance liquid chromatography 15.12.3. Ion-exchange HPLC 15.13. Argentina Boronate Affinity Tests Market Forecast, By Indication 15.13.1. Type 1 diabetes 15.13.2. Type 2 diabetes 15.14. Argentina Boronate Affinity Tests Market Forecast, By Technology 15.14.1. Boronate Affinity Chromatography 15.14.2. Boronate Affinity high-performance liquid chromatography 15.14.3. Ion-exchange HPLC 15.15. Rest of South America Boronate Affinity Tests Market Forecast, By Indication 15.15.1. Type 1 diabetes 15.15.2. Type 2 diabetes 15.16. Rest of South America Boronate Affinity Tests Market Forecast, By Technology 15.16.1. Boronate Affinity Chromatography 15.16.2. Boronate Affinity high-performance liquid chromatography 15.16.3. Ion-exchange HPLC 15.17. South America Boronate Affinity Tests Market Attractiveness Analysis 15.17.1. By Indication 15.17.2. By Technology 15.18. PEST Analysis 15.19. Key Trends 15.20. Key Developments 16. Company Profiles 16.1. Market Share Analysis, by Company 16.2. Competition Matrix 16.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications, and R&D investment 16.2.2. New Product Launches and Product Enhancements 16.2.3. Market Consolidation 16.2.3.1. M&A by Regions, Investment and Applications 16.2.3.2. M&A Key Players, Forward Integration and Backward Integration 16.3. Company Profiles: Key Players 16.3.1. Abbott Laboratories 16.3.1.1. Company Overview 16.3.2. Financial Overview 16.3.2.1. Product Portfolio 16.3.2.2. Business Strategy 16.3.2.3. Recent Developments 16.3.2.4. Development Footprint 16.3.3. A. Menarini Diagnostics s.r.l 16.3.4. GREENCORSS MEDIS Corp 16.3.5. Alere Inc. 16.3.6. Trinity Biotech 16.3.7. HUMAN DIgnostics 16.3.8. HemoCue 16.3.9. ARKRAY, Inc. 16.3.10. Beckman Coulter, Inc 16.3.11. Bio-Rad Laboratories, Inc. 16.3.12. Diazyme Laboratories, Inc. 16.3.13. EKF Diagnostics Holdings plc 16.3.14. OSANG Healthcare Co. Ltd 16.3.15. PTS Diagnostics 16.3.16. Roche Diagnostics 16.3.17. Siemens Healthineers 16.3.18. Tosoh Bioscience, Inc. 16.3.19. Trinity Biotech plc

About This Report

Report ID81379
Category Healthcare
Published DateJanuary 2021
Updated DateOct 2021
Contact Us